IGC Pharma Completes Enrollment in Phase 2 CALMA

New Post Public Reply Private Reply Replies (0) Message Board
louied91
245
IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026

https://www.accessnewswire.com/newsroom/en/bi...xp-1227682  

POTOMAC, MD / ACCESS Newswire / September 28, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company" today announced it has completed enrollment in its CALMA Phase 2 trial evaluating lead asset, IGC-AD1, for agitation in Alzheimer's dementia.

Enrollment complete; final participant dosing expected to conclude in early November; topline results expected Q4 2026

CALMA achieved target enrollment with 168 participants randomized, including planned over-enrollment designed to strengthen the evaluable dataset for end-of-treatment, secondary, and exploratory analyses. Following the protocol-defined six-week treatment period, final participant dosing is expected to complete in early November, after which the Company expects to proceed toward database lock, unblinding, and topline analysis, with topline results expected in the fourth quarter of 2026.

"With target enrollment complete, CALMA has officially transitioned from recruitment to the final stage ahead of topline results," said Ram Mukunda, Chief Executive Officer of IGC Pharma. "Our focus is now on patient follow-up and database lock as we prepare this 168-patient dataset for rigorous scientific and regulatory evaluation and potential next-stage development."

CALMA is a multicenter, randomized, double-blind, placebo-controlled Phase 2 trial evaluating IGC-AD1, an investigational oral solution dosed twice daily for six weeks, for agitation in Alzheimer's dementia. The primary endpoint is change in agitation from baseline to week six on the Cohen-Mansfield Agitation Inventory. The trial was conducted across clinical sites in the United States and Canada, including academic and specialty centers such as Baycrest Academy for Research and Education, Butler Hospital - Memory and Aging Program, Hamilton Health Sciences, McGill University, and Miami Jewish Health.

The enrolled population had an average age of approximately 78 years, reflecting an older Alzheimer's dementia population, and approximately 53% of participants were female. Based on available race data, approximately 77% of participants were White, 16% were Black or African American, and the remaining participants identified as other races or were not listed.

Agitation is one of the hardest symptoms of Alzheimer's dementia for families and caregivers to manage. It can contribute to emergency care, caregiver distress, earlier placement in residential care, and increased healthcare costs. IGC-AD1 is being developed as a potential treatment option for this high-burden patient population.

The Data Safety Monitoring Committee has conducted periodic safety reviews and at each review to date, has recommended that the trial continue without modification. The Company remains blinded to treatment assignment. As of the Company's most recent safety reporting, blinded safety monitoring had not identified any treatment-related serious adverse events as related to study treatment. Safety data remain subject to final review and analysis after database lock and unblinding.

"Completing enrollment is a defining clinical milestone for IGC Pharma," Mr. Mukunda continued. "We are grateful to the participants, caregivers, investigators, and clinical teams who made CALMA possible, and we look forward to reporting topline results."
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 96

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 91

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Cracking Life Insurance Needs: John Dorsa's Insights

Updated Category News Views 137

Life Insurance: A Necessary Puzzle Life’s uncertainties have a way of putting a wrench in our plans, and nothing screams uncertainty like figuring out life insurance. But fret not! HelloNation’s got insights on this financial maze, and they’ve roped in insurance pro John Dorsa from Ridgeland to help out. Calculating Coverage Needs Forget the one-size-fits-all...

Continue Reading
Lear Gears Up for Goldman Sachs Event Spotlight

Updated Category News Views 132

Lear Prepares for the Big Stage in London Autumn leaves and industry insights are falling in full swing as Lear Corporation gets its ducks in a row for the upcoming Goldman Sachs 18th Annual Industrials & Autos Week. Kicking off on December 3, 2026, this gathering in London isn't just another checkbox on their corporate calendar—it's a prime moment in the spotlight....

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 149

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 207

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 110

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
Ave7® Pioneers AI-Driven Marketplace Evolution

Updated Category News Views 99

AI Reshapes the Agency Paradigm Nobody saw this coming a decade ago, but here we are—AI's taking the wheel, but with humans still riding shotgun. The agency world, particularly the one dealing with e-commerce giants like Amazon, Walmart, and Target, has flipped on its head. Ave7® steps up as the frontrunner, adapting faster than a broker's reflex after a market bell....

Continue Reading
Grupo Supervielle's Q3 2026: Back to Growth Path

Updated Category News Views 66

Mounting Momentum in Loans and Asset Quality Grupo Supervielle, the Argentine financial player, has been tinkering with its gears to navigate the bumpy roads of 2026. In the third quarter, the company reports a gentle uptick in net loans—up 1.3% sequentially. This was particularly felt in September, with loans increasing 3.7%. Holding Their Own Against the Industry...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 48

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading

Top 5 Most Recently Viewed Articles

Vancity Achieves Remarkable Q2 Performance Amid Strategic Shift

Updated Category News Views 345

Vancity Reports Strong Financial Performance in Q2 Vancity recently showcased its outstanding financial results for the second quarter, demonstrating impressive growth across various metrics and solidifying its commitment to its members. This performance is part of Vancity's transformative vision to enhance member experience while making significant contributions to local...

Continue Reading
Celebrating Courtney Rollings Latham's Exceptional Contributions

Updated Category News Views 283

Honoring Courtney Rollings Latham, M.Ed, BCBA It brings us great joy to acknowledge Courtney Rollings Latham, M.Ed, BCBA, for achieving the status of a Pinnacle Professional Member in The Inner Circle of Excellence. This recognition showcases her steadfast commitment to enhancing the fields of Behavior Analysis and Special Education. A Passionate Educator and Analyst...

Continue Reading
Savers Value Village, Inc. Reveals Sales Growth and Conference Plans

Updated Category News Views 158

Savers Value Village, Inc. Reports Preliminary Sales Results BELLEVUE, Wash. – Savers Value Village, Inc. (NYSE: SVV) has released its preliminary net sales for the recent quarter along with its full year results for fiscal 2024. This announcement coincides with the Company’s upcoming participation in the ICR Conference scheduled for mid-January 2025. Sales...

Continue Reading
Empowering Salon Professionals Through Natural Disasters Support

Updated Category News Views 241

Empowering Professionals in the Face of Adversity Natural disasters can strike unexpectedly, causing chaos and distress. My Salon Suite®, a franchise dedicated to providing beauty, health, and wellness professionals with personal spaces for their businesses, has been at the forefront of community support during such challenging times. As we navigate through the hurricane...

Continue Reading
Major Revenue Surge: POP Culture Group's Impressive FY2025 Results

Updated Category News Views 201

POP Culture Group Achieves Record Revenue in FY2025 In a remarkable financial breakthrough, POP Culture Group Co., Ltd. (Nasdaq: CPOP) has announced its fiscal year 2025 results, showcasing an incredible revenue surge that exceeded $100 million for the first time. This milestone represents a significant leap, with revenue increasing by 127% compared to the previous fiscal...

Continue Reading